1. Home
  2. Live Updates
  3. Company trappsol

Live Breaking News & Updates on Company trappsol

Stay informed with the latest breaking news from Company trappsol on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Company trappsol and stay connected to the pulse of your community

Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer's Disease from the U.S. Patent and Trademark Office -January 29, 2024 at 09:16 am EST

Cyclo Therapeutics, Inc. , a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today...

United-states , Company-trappsol , Exchange-commission , Nasdaq , Trademark-office , Cyclo-therapeutics-inc , Cyclo-therapeutics , United-states-patent , Treating-alzheimer , Cyclo-therapeutic , Expanded-access

Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer's Disease from the U.S. Patent and Trademark Office

Cyclo Therapeutics Announces Allowance of Patent Application for Treatment of Alzheimer's Disease from the U.S. Patent and Trademark Office
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Jenene-thomas , Company-trappsol , Exchange-commission , Trademark-office , Cyclo-therapeutics-inc , Nasdaq , United-states-patent , Treating-alzheimer , Cyclo-therapeutics , Cyclo-therapeutic-trappsol , Expanded-access

Cyclo Therapeutics Announces Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol® Cyclo™ Clinical Program for the Treatment of Niemann-Pick Disease Type C1

Ongoing pivotal Phase 3 study evaluating Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1


FDA feedback provides direction for the comparative interim analysis


With aligned...

United-states , Michael-lisjak , Cyclo-therapeutics-inc , Drug-administration , Company-trappsol , Nasdaq , Company-transport , Exchange-commission , Business-development-for-cyclo-therapeutics , Cyclo-therapeutics , Chief-executive-officer , Orphan-disease

Cyclo Therapeutics (CYTH) Reports Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol Cyclo

Cyclo Therapeutics (CYTH) Reports Positive Outcome from Type C Meeting with the U.S. FDA Discussing Trappsol Cyclo
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Michael-lisjak , Company-transport , Business-development-for-cyclo-therapeutics , Nasdaq , Company-trappsol , Cyclo-therapeutics-inc , Drug-administration , Cyclo-therapeutics , Scott-fine , Chief-executive-officer , Orphan-disease

Cyclo Therapeutics to Present at the 20th Annual WORLDSymposium™ 2024

GAINESVILLE, Fla.--(BUSINESS WIRE)--Nov 21, 2023--

California , United-states , San-diego , Jenene-thomas , Caroline-hastings , Cyclo-therapeutics-inc , Exchange-commission , Company-trappsol , Research-on-lysosomal-diseases , Nasdaq , Open-phase , We-re-organizing-research

Cyclo Therapeutics Reports Third Quarter 2023 Financial Results

Cyclo Therapeutics Reports Third Quarter 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Jenene-thomas , Wilson-sonsini-goodrich-rosati , Shawn-cross , Nasdaq , Critical-path-institute-scientific-breakthrough-summit , Company-trappsol , Company-phase , Rafael-holdings-inc , Cyclo-therapeutics-inc , Exchange-commission , Fox-rothschild

Cyclo Therapeutics Announces Early Exercise of Warrants by Board Members, Management and a Significant Shareholder Resulting in Cash Proceeds of $2.4 Million

Issues New Warrants to this Investment Group for Possible Additional Funding of Up to $3.47 Million

...

United-states , William-conkling , Company-trappsol , Rafael-holding , Rafael-holdings-inc , Nasdaq , Exchange-commission , Cyclo-therapeutics-inc , Cyclo-therapeutics , Original-warrants , New-warrants , Rafael-holdings

Cyclo Therapeutics to Present at 8th Annual Dawson James Conference

Live webcast presentation on Thursday, October 12th at 12:00 PM ET

...

United-states , New-jersey , Maryland , New-york , Dawson-james , Boca-raton , Nasdaq , Cyclo-therapeutics-inc , Life-science-health-care , Company-trappsol , Cyclo-therapeutics , Chief-executive-officer

Cyclo Therapeutics Reports Second Quarter 2023 Financial Results

Continued strong enrollment of pivotal Phase 3 global study evaluating Trappsol® Cyclo™ for Niemann-Pick Disease Type C1 on track to complete enrollment by year end 2023


Company anticipates...
-Today at 08:13 am- MarketScreener

China , United-states , Company-trappsol , Nasdaq , Rafael-holdings-inc , Exchange-commission , European-patent-office-for-trappsol , Cyclo-therapeutics-inc , Cyclo-therapeutics , Chief-executive-officer , Rafael-holdings

Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc.

Cyclo Therapeutics, Inc. , a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today...

United-states , William-conkling , Company-trappsol , Exchange-commission , Rafael-pharmaceuticals-inc , Cyclo-therapeutics-inc , Rafael-holdings-inc , Cornerstone-pharmaceuticals-inc , Rafael-holdings , Nasdaq , Cyclo-therapeutics , Chief-executive-officer